𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

✍ Scribed by C.R. Chapple; T. Rechberger; S. Al-Shukri; P. Meffan; K. Everaert; M. Huang; A. Ridder; the YM-905 Study Group


Book ID
109051113
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
190 KB
Volume
93
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES